Skip to main content
European Commission logo print header

AI supported picture analysis in large bowel camera capsule endoscopy

Project description

AI algorithms to advance novel low-invasive endoscopy procedures

Colon capsule endoscopy (CCE) is a new technology with the potential to replace most of the current optical colonoscopy procedures, which are associated with discomfort and complications. The CCE has a lower complication rate and does not require a hospital setting but includes a time-consuming manual reading and is prone to human error. The EU-funded AICE project aims to create an AI-supported pathway for CCE diagnostics, making it clinically viable. The AICE will use a diverse collection of existing patient data to complete and validate the AI algorithms for CCE diagnostics, create a clinical support system for data handling, storage and transmission and promote the integration of the AICE solution into clinical practice.

Objective

Millions of Europeans undergo optical colonoscopy (OC) every year. OC may be associated with discomfort, complications and sick-days, which affect acceptability, and constitutes a heavy burden on European hospital capacities. Colon capsule endoscopy (CCE) is a new technology, which has the potential to replace 50 ? 65 % of all OCs. CCE is preferred by patients, has a lower complication rate and can be performed out of hospital. CCE holds great potential for both patients and hospitals. However, the diagnostic process of CCE includes a time-consuming manual reading done by trained personnel and is expensive and prone to human error. For CCE to be a viable alternative to OC these challenges need to be addressed. Thus, our goal is to create a complete and validated AI-assisted pathway that improves CCE diagnostics making the technology clinically viable for the good of patients, health care systems and society. We have already completed development of several AI algorithms (AIA) for CCE diagnostics, and more will be completed within 1 ?2 years. The AICE concept will focus on: 1) completing development of the remaining AIAs, 2) external validation the all AIAs, 3) creating a clinical support system for data handling, storage and transmission, 4) developing a diagnostic pathway that considers quality, efficiency, patient preferences, ethics and economy 5) promotes the integration of AICE solutions into clinical practice via guidelines and upscaling adjustments. To achieve these goals, AICE will use an unprecedented large and diverse collection of existing patient data from nation-wide clinical studies, and will include extensive initiatives in the fields of ethics, communication and patient engagement. To ensure the right competences are present, AICE brings together clinical researchers, epidemiologists, data scientists, digital health experts, health economists, ethics researchers, SMEs, communication experts and experts in regulatory affairs.

Coordinator

REGION SYDDANMARK
Net EU contribution
€ 1 508 056,00
Address
DAMHAVEN 12
7100 Vejle
Denmark

See on map

Region
Danmark Syddanmark Sydjylland
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Links
Total cost
€ 1 508 056,25

Participants (8)

Partners (3)